Celecoxib and Etoricoxib may reduce risk of ischemic stroke in patients with rheumatoid arthritis: A nationwide retrospective cohort study

BACKGROUND AND PURPOSE: Previous studies reported conflicting results about the risk of ischemic stroke associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with rheumatoid arthritis (RA). We aimed to investigate two specific COX-2 inhibitors, Celecoxib and Etoricoxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Acer I-Hung, Lee, Yung-Heng, Perng, Wuu-Tsun, Chiou, Jeng-Yuan, Wang, Yu-Hsun, Lin, Lichi, Wei, James Cheng-Chung, Tsou, Hsi-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630581/
https://www.ncbi.nlm.nih.gov/pubmed/36341096
http://dx.doi.org/10.3389/fneur.2022.1018521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630581/
https://www.ncbi.nlm.nih.gov/pubmed/36341096
http://dx.doi.org/10.3389/fneur.2022.1018521

Ejemplares similares